2003 Patients Pharma 
World of DTC Marketing
MAY 26, 2021
Today, AbbVie charges approximately $77,000 for a year’s supply of Humira—470% more than when the drug was launched in 2003. Today, Imbruvica is priced at $181,529 per year for a patient taking three pills per day, compared to $99,776 per year at launch. net revenue from Humira.
Healthcare Success
OCTOBER 17, 2024
Struggling with burnout while maintaining high-quality healthcare services that patients love? Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business. It was scary.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 9, 2022
The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. It is, she said, the uniting of industry with researchers and researchers with patients, and so forth, that is at the heart of this journey currently being undertaken.
Silver Line CRM
SEPTEMBER 24, 2020
Reading time: 4 minutes A patient support network isn’t made up of just doctors or nurses. Through contracting with pharmaceutical and biotech companies, VMS BioMarketing provides clinical educator solutions focused on empowering healthcare providers and patients through product support, education, and training.
pharmaphorum
DECEMBER 6, 2022
A few decades ago, gathering genetic data on the scale of the 100,000 Genomes Project would have been unthinkable – it was only in 2003 that the entire human genome was mapped. Hope for patients. The importance of health data to the life science industry is growing just as rapidly as the technology enabling its capture is advancing.
PM360
JUNE 11, 2022
Qualitative and quantitative research help pharma brand teams understand physician and patient attitudes, behaviors, and perspectives. For example, consider a pharma brand team trying to market its newest triple inhaler therapy for the treatment of COPD against its top competitor. Seize the Initiative.
pharmaphorum
DECEMBER 22, 2022
Bingham replied that pharma, biotech, and academia all need to come up with new approaches. However, she continued, pharma generally doesn’t voluntarily go down such a route. Bingham continued that the Inflation Reduction Act would hit cancer patients heavily in the US as there would be a disincentive to innovate.
Expert insights. Personalized for you.
180 
Let's personalize your content